Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study [Congenital Heart Disease]

Conclusions— Closure of atrial septal defect with the AMPLATZER Septal Occluder is safe and effective. The rate of hemodynamic compromise and cardiac erosion is rare. The risk factors for cardiac erosion after device closure are not yet clear. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00650936.

http://circinterventions.ahajournals.org/cgi/content/short/10/8/e004212?rss=1

Source: Circulation: Cardiovascular Interventions - August 11, 2017 Category: Cardiology Authors: Turner, D. R., Owada, C. Y., Sang, C. J., Khan, M., Lim, D. S. Tags: Congenital Heart Disease Source Type: research